R&D

Case report on the treatment of Obsessive Compulsive Behavior Disorder (CSBD) with naltrexone hydrochloride implant

Source：Asian Journal of Psychiatry Date：2025-12-05

snshd_14746369126295351916.jpg

Prev： World Drug Report 2025｜Global reference on drug markets, trends and policy developments

Next： Research findings of Shanhai Mental Health Center were Published in Drug and Alcohol Dependence

Back

You May Like：

Tel：0086 755 84208896

Addr：Changfang Lighting Industrial Factory Building C2-101, Zhukeng Community, Longtian Street, Pingshan District, Shenzhen China

Follow Us


Scan the code to follow Shankang!

Copyright © 2025-2026 Shenzhen Shankang Pharmaceutical Technology Co., Ltd 粤ICP备20040229号-1